New Results
N and O glycosylation of the SARS-CoV-2 spike protein
View ORCID ProfileMiloslav Sanda, Lindsay Morrison, Radoslav Goldman
doi: https://doi.org/10.1101/2020.07.05.187344
Miloslav Sanda
1Georgetown University, Department of Oncology, 3800 Reservoir Rd NW, Washington, D.C. 20057
3Georgetown University, Clinical and Translational Glycoscience Research Center, 3800 Reservoir Rd NW, Washington, D.C. 20057
Lindsay Morrison
4Waters Corporation Inc., Beverly, MA 01915 USA
Radoslav Goldman
1Georgetown University, Department of Oncology, 3800 Reservoir Rd NW, Washington, D.C. 20057
2Georgetown University, Department of Biochemistry and Molecular & Cellular Biology, 3800 Reservoir Rd NW, Washington, D.C. 20057
3Georgetown University, Clinical and Translational Glycoscience Research Center, 3800 Reservoir Rd NW, Washington, D.C. 20057

- Supplemental_Figures[supplements/187344_file02.pdf]
Posted July 06, 2020.
N and O glycosylation of the SARS-CoV-2 spike protein
Miloslav Sanda, Lindsay Morrison, Radoslav Goldman
bioRxiv 2020.07.05.187344; doi: https://doi.org/10.1101/2020.07.05.187344
Subject Area
Subject Areas
- Biochemistry (10312)
- Bioengineering (7633)
- Bioinformatics (26237)
- Biophysics (13472)
- Cancer Biology (10647)
- Cell Biology (15359)
- Clinical Trials (138)
- Developmental Biology (8462)
- Ecology (12775)
- Epidemiology (2067)
- Evolutionary Biology (16789)
- Genetics (11370)
- Genomics (15427)
- Immunology (10575)
- Microbiology (25083)
- Molecular Biology (10171)
- Neuroscience (54229)
- Paleontology (398)
- Pathology (1660)
- Pharmacology and Toxicology (2883)
- Physiology (4324)
- Plant Biology (9207)
- Synthetic Biology (2543)
- Systems Biology (6760)
- Zoology (1457)